cnbc.com / .cnbc-com-health-care / Page 3

Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.

Robert F. Kennedy Jr. is President-elect Donald Trump's pick to lead the Department of Health and Human Services.

The CDC said 104 people in 14 states were infected in the E. coli outbreak linked to McDonald's.

Trump's FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.

President-elect Donald Trump's agenda carries risks and rewards for various investment sectors, market experts said.

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

More than two million babies died in the first 20 days of their lives in 2022, and a startup, Biorithm, hopes to help prevent this with its monitoring device.

Eli Lilly's cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

The complaint is the latest move in a bitter legal fight between the U.S.'s three largest so-called pharmacy benefit managers, or PBMs, and the FTC.

Trump's selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries cautious of changes to come.